Disciplined Growth Investors Inc Mimedx Group, Inc. Transaction History

Disciplined Growth Investors Inc

$4.6 Billion
Q4 2024

A detailed history of Disciplined Growth Investors Inc transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Disciplined Growth Investors Inc holds 347,946 shares of MDXG stock, worth $2.78 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

347,946

Previous 355,387 2.09%

Holding current value

$2.78 Million

Previous $2.1 Million 59.38%

% of portfolio

0.07%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$5.51 - $9.75 $40,999 - $72,549	-7,441 Reduced 2.09%	347,946 $3.35 Million
Q3 2024 Nov 14, 2024	BUY	$5.65 - $7.76 $15,464 - $21,239	2,737 Added 0.78%	355,387 $2.1 Million
Q2 2024 Aug 15, 2024	BUY	$6.16 - $8.08 $4,478 - $5,874	727 Added 0.21%	352,650 $2.44 Million
Q1 2024 May 15, 2024	BUY	$7.61 - $8.63 $272,651 - $309,195	35,828 Added 11.33%	351,923 $2.71 Million
Q4 2023 Feb 14, 2024	SELL	$5.7 - $9.14 $23,985 - $38,461	-4,208 Reduced 1.31%	316,095 $2.77 Million
Q3 2023 Nov 14, 2023	SELL	$6.35 - $8.16 $20,332 - $26,128	-3,202 Reduced 0.99%	320,303 $2.34 Million
Q2 2023 Aug 14, 2023	BUY	$3.14 - $6.61 $4,424 - $9,313	1,409 Added 0.44%	323,505 $2.14 Million
Q1 2023 May 15, 2023	SELL	$2.97 - $4.81 $37,463 - $60,673	-12,614 Reduced 3.77%	322,096 $1.1 Million
Q4 2022 Feb 14, 2023	BUY	$2.63 - $3.45 $6,727 - $8,825	2,558 Added 0.77%	334,710 $930,000
Q3 2022 Nov 15, 2022	BUY	$2.71 - $4.22 $200 - $312	74 Added 0.02%	332,152 $953,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $5.0 $5,382 - $8,490	1,698 Added 0.51%	332,078 $1.15 Million
Q1 2022 May 16, 2022	BUY	$4.27 - $6.27 $49,736 - $73,032	11,648 Added 3.65%	330,380 $1.56 Million
Q4 2021 Feb 14, 2022	SELL	$5.7 - $8.48 $68,724 - $102,243	-12,057 Reduced 3.64%	318,732 $1.93 Million
Q3 2021 Nov 15, 2021	SELL	$5.52 - $15.83 $8,412 - $24,124	-1,524 Reduced 0.46%	330,789 $2.01 Million
Q2 2021 Aug 16, 2021	BUY	$9.02 - $12.72 $523,899 - $738,803	58,082 Added 21.18%	332,313 $4.16 Million
Q1 2021 May 17, 2021	SELL	$8.48 - $11.28 $680,689 - $905,445	-80,270 Reduced 22.64%	274,231 $2.83 Million
Q4 2020 Feb 16, 2021	SELL	$5.32 - $10.17 $183,023 - $349,878	-34,403 Reduced 8.85%	354,501 $3.22 Million
Q3 2020 Nov 16, 2020	SELL	$4.99 - $7.0 $688 - $966	-138 Reduced 0.04%	388,904 $2.47 Million
Q2 2020 Aug 14, 2020	SELL	$3.2 - $5.5 $43,424 - $74,635	-13,570 Reduced 3.37%	389,042 $2.1 Million
Q1 2020 May 15, 2020	SELL	$3.17 - $7.54 $249,897 - $594,393	-78,832 Reduced 16.37%	402,612 $1.41 Million
Q4 2019 Feb 14, 2020	SELL	$4.67 - $7.58 $25,750 - $41,796	-5,514 Reduced 1.13%	481,444 $3.65 Million
Q3 2019 Nov 15, 2019	BUY	$3.99 - $5.71 $3,499 - $5,007	877 Added 0.18%	486,958 $2.39 Million
Q2 2019 Aug 14, 2019	BUY	$2.37 - $5.57 $6,891 - $16,197	2,908 Added 0.6%	486,081 $1.97 Million
Q1 2019 May 14, 2019	SELL	$1.84 - $3.74 $1,288 - $2,618	-700 Reduced 0.14%	483,173 $1.7 Million
Q4 2018 Feb 13, 2019	SELL	$1.15 - $6.45 $256,418 - $1.44 Million	-222,973 Reduced 31.54%	483,873 $866,000
Q3 2018 Nov 16, 2018	SELL	$3.22 - $6.33 $18,882 - $37,119	-5,864 Reduced 0.82%	706,846 $4.37 Million
Q2 2018 Aug 15, 2018	SELL	$5.39 - $8.96 $5,368 - $8,924	-996 Reduced 0.14%	712,710 $4.55 Million
Q1 2018 May 17, 2018	SELL	$6.69 - $17.96 $4,381 - $11,763	-655 Reduced 0.09%	713,706 $4.98 Million
Q4 2017 Feb 15, 2018	BUY	$10.87 - $13.9 $220,780 - $282,322	20,311 Added 2.93%	714,361 $9.01 Million
Q3 2017 Nov 14, 2017	BUY	$11.86 - $17.34 $8.23 Million - $12 Million	694,050	694,050 $8.25 Million

Others Institutions Holding MDXG

# of Institutions

232

Shares Held

101M

Call Options Held

34.6K

Put Options Held

36.5K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $907M
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Growth Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Growth Investors Inc with notifications on news.

Account

Disciplined Growth Investors Inc Mimedx Group, Inc. Transaction History